Baseline characteristics of patients in the glutamine and placebo groups
| Glutamine (n=29) | Placebo (n=33) | |
|---|---|---|
| Sex (n (%)) | ||
| Males | 17 (58.6) | 19 (57.6) |
| Females | 12 (41.4) | 14 (42.4) |
| Age (median, range) | 63 (44–76) | 61 (35–75) |
| Treatment setting (n (%)) | ||
| Adjuvant | 8 (27.6) | 10 (30.3) |
| Advanced | 21 (72.4) | 23 (69.7) |
| Performance status (n (%)) | ||
| 0 | 20 (69.0) | 22 (66.7) |
| 1 | 6 (20.7) | 8 (24.2) |
| 2 | 3 (10.3) | 3 (9.1) |
| Body mass index (mean (SD)) | 22.8 (2.5) | 23.2 (2.6) |